Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Round cell tumours of bone

A Roessner¹, H Jürgens

¹Institut für Pathologie, Otto von Guericke-Universität Magdeburg, Germany.

Pathology, Research and Practice

|December 1, 1993

Summary

Ewing's sarcoma, a rare cancer, is now better understood due to its shared chromosome translocation with malignant peripheral neuroectodermal tumors. This discovery aids in diagnosis and understanding prognosis, particularly for tumors with neural differentiation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Bone tumours].

Der Pathologe·2020

Same author

[Narrow band imaging for evaluation of laryngeal mucosal lesions].

HNO·2017

Same author

Articulating polymethylmethacrylate (PMMA) spacers may have an immunomodulating effect on synovial tissue.

The bone & joint journal·2016

Same author

[Inaugural speech of the congress president of the German Society of Pathology at the 98th annual congress].

Der Pathologe·2014

Same author

[98th Annual Conference of the German Society for Pathology : Berlin, 12-15 June 2014].

Der Pathologe·2014

Same author

BRCA1 promoter methylation is a marker of better response to platinum-taxane-based therapy in sporadic epithelial ovarian cancer.

Journal of cancer research and clinical oncology·2014

Area of Science:

Oncology
Pathology
Genetics

Background:

Ewing's sarcoma is a rare tumor with a controversial histogenesis.
Chemotherapy has significantly improved its prognosis, increasing oncological interest.
Previous theories suggested origins in various mesenchymal cells or neuroectodermal genesis.

Purpose of the Study:

To clarify the histogenesis of Ewing's sarcoma.
To improve the differential diagnosis of Ewing's sarcoma using immunohistological methods.
To investigate the prognostic implications of neural differentiation in Ewing's sarcoma.

Main Methods:

Analysis of chromosome translocation 11;22 shared between Ewing's sarcoma and malignant peripheral neuroectodermal tumors.
Application of immunohistological methods for differential diagnosis.
Evaluation of neural markers (neuron specific enolase, synaptophysin, chromogranin) and Homer Wright pseudo-rosettes.

Main Results:

The common chromosome translocation 11;22 provides strong evidence for a shared origin between Ewing's sarcoma and malignant peripheral neuroectodermal tumors.
Immunohistology effectively distinguishes Ewing's sarcoma from lymphoma and embryonal rhabdomyosarcoma.
Tumors with neural differentiation show a poorer prognosis under chemotherapy.

Conclusions:

The shared chromosome translocation 11;22 is a key finding in understanding Ewing's sarcoma.
Immunohistochemistry is crucial for accurate diagnosis and differentiation.
Identifying neural markers is important for predicting treatment outcomes in Ewing's sarcoma.

Related Experiment Videos